Texas Children's Hospital
Patent Applications and Registrations
Patent applications and USPTO patent grants for Texas Children's Hospital.The latest application filed is for "targeting ligands for tau pathology".
- Texas Children's Hospital - Houston TX US
Trademarks
| Patent | Date |
|---|---|
| Targeting Ligands For Tau Pathology App 20220283187 - Annapragada; Ananth ; et al. | 2022-09-08 |
| Targeted Contrast Agents For Mri Of Alpha-synuclein Deposition App 20220265868 - Tanifum; Eric A. ; et al. | 2022-08-25 |
| Targeting nanoparticles Grant 11,312,685 - Woodside , et al. April 26, 2 | 2022-04-26 |
| Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR signatures Grant 11,241,510 - Annapragada , et al. February 8, 2 | 2022-02-08 |
| Targeted Contrast Agents For Mri Of Amyloid Deposition App 20220023445 - Tanifum; Eric A. ; et al. | 2022-01-27 |
| MRI imaging of amyloid plaque using liposomes Grant 11,141,495 - Annapragada , et al. October 12, 2 | 2021-10-12 |
| Targeted contrast agents for MRI of amyloid deposition Grant 11,116,854 - Tanifum , et al. September 14, 2 | 2021-09-14 |
| Targeted Contrast Agents For Mri Of Alpha-synuclein Deposition App 20210252170 - Tanifum; Eric A. ; et al. | 2021-08-19 |
| Physiologic Cardiovascular Ph Balanced Counter Current Electrolyte Transfer And Fluid Removal System App 20210236710 - DENISON; Richard ; et al. | 2021-08-05 |
| Targeted Contrast Agents For Mri Of Amyloid Deposition App 20210236662 - Tanifum; Eric A. ; et al. | 2021-08-05 |
| Liposomal gadolinium (GD) contrast agent "NMRX" for T1-MRI Grant 11,052,162 - Annapragada , et al. July 6, 2 | 2021-07-06 |
| Targeted Contrast Agents For Mri Of Amyloid Deposition App 20210170055 - Tanifum; Eric A. ; et al. | 2021-06-10 |
| Targeting Ligands For Tau Pathology App 20210128755 - Annapragada; Ananth ; et al. | 2021-05-06 |
| Mri Imaging Of Amyloid Plaque Using Liposomes App 20200179540 - Annapragada; Ananth V. ; et al. | 2020-06-11 |
| Mri Imaging Of Amyloid Plaque Using Liposomes App 20200069820 - Annapragada; Ananth ; et al. | 2020-03-05 |
| MRI imaging of amyloid plaque using liposomes Grant 10,537,649 - Annapragada , et al. Ja | 2020-01-21 |
| Novel Liposomal Gadolinium (gd) Contrast Agent "nmrx" For T1-mri App 20190255196 - ANNAPRAGADA; Ananth ; et al. | 2019-08-22 |
| Hydrophilic Fluorinated Molecules For Liposomal 19f Mri Probes With Unique Mr Signatures App 20180154025 - Annapragada; Ananth ; et al. | 2018-06-07 |
| MRI imaging of amyloid plaque using liposomes Grant 9,744,251 - Annapragada , et al. August 29, 2 | 2017-08-29 |
| Mri Imaging Of Amyloid Plaque Using Liposomes App 20170080111 - Annapragada; Ananth ; et al. | 2017-03-23 |
| MRI Imaging of Amyloid Plaque Using Liposomes App 20160101197 - Annapragada; Ananth V. ; et al. | 2016-04-14 |
| Hospital Patient Gown App 20080000006 - Ochoa; Yvette M. ; et al. | 2008-01-03 |
| Apparatus for supporting medical fluids Grant 6,971,617 - Nguyen December 6, 2 | 2005-12-06 |
| Vest for the physiological monitoring of children Grant 5,549,116 - Mauer August 27, 1 | 1996-08-27 |
| NCAGE Code | 492P2 | TEXAS CHILDREN'S HOSPITAL |
| S.A.M. Registration | 492P2 [74615394] | TEXAS CHILDREN'S HOSPITAL |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 